封面
市场调查报告书
商品编码
1741475

医用人工材料市场按产品类型、应用、最终用户和地区划分

Medical Engineered Materials Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025年医用人工材料市场规模预计为315.8亿美元,预计到2032年将达到756.9亿美元,2025年至2032年的复合年增长率为13.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 315.8亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 13.30% 2032年价值预测 756.9亿美元

医学工程材料在医疗保健行业中发挥着至关重要的作用,为广泛的应用提供创新的解决方案。这些材料经过专门设计,可满足医疗设备、植入和设备的独特要求。它们具有卓越的强度、耐用性和生物相容性,可确保医疗保健解决方案的安全有效。材料科学与工程的重大进步正在扩大陶瓷、金属、聚合物和复合材料等材料在医疗保健领域的应用。正在开发的新型生物工程材料可以紧密模拟人体组织并有助于组织再生。这些进步是由改善患者预后的需求以及医疗程序和治疗日益复杂所驱动的。总体而言,医学工程材料产业在开发创新材料解决方案方面发挥关键作用,这些解决方案将把医疗保健提升到新的水平。

市场动态:

全球医用人工材料市场的成长受到多种因素的推动。心血管疾病、糖尿病和癌症等慢性疾病的日益流行预计将推动对医疗设备和植入的需求。这些材料具有生物相容性、耐用性和灵活性等优异的性能,这对于开发先进的医疗设备至关重要。全球老年人口的增加促进了市场的成长。老年人口更容易患慢性疾病,需要专门治疗,这就需要使用医用人工材料。此外,材料科学的技术进步,如生物基材料和奈米技术涂层的开发,正在进一步推动市场成长。

然而,市场面临许多挑战。美国食品药物管理局(FDA) 等监管机构制定的严格法规和品质标准,可能对市场进入者构成障碍。遵守这些法规并获得新材料的监管核准既耗时又昂贵。此外,开发和生产医用人工材料的高成本也可能成为市场成长的限制因素。

本研究的主要特点

  • 本研究报告对全球医用人工材料市场进行了详细的分析,并以2024年为基准年,给出了预测期(2025-2032)的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在商机,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 全球医用人工材料市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球医用人工材料市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 可以透过用于分析全球医用人工材料市场的各种策略矩阵来促进相关人员的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 全球医疗义肢材料市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球医疗义肢材料市场(依产品类型),2020 年至 2032 年

  • 金属生医材料
  • 陶瓷生医材料
  • 聚合物生医材料
  • 天然生医材料
  • 复合生物材料
  • 其他的

6. 全球医疗义肢材料市场(按应用划分),2020 年至 2032 年

  • 心血管系统
  • 整形外科
  • 牙科
  • 整形外科
  • 伤口癒合
  • 神经系统
  • 其他的

7. 全球医疗义肢材料市场(按最终用户划分),2020 年至 2032 年

  • 医院
  • 诊所
  • 研究机构
  • 其他的

8. 2020-2032 年全球医疗义肢材料市场(按地区)

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十章 竞争格局

  • Evonik Industries AG
  • Covestro AG
  • BASF SE
  • Solvay
  • SABIC
  • Trelleborg AB
  • DSM
  • Celanese Corporation
  • DuPont de Nemours Inc.
  • Others

第 11 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6308

Medical Engineered Materials Market is estimated to be valued at USD 31.58 Bn in 2025 and is expected to reach USD 75.69 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 31.58 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.30% 2032 Value Projection: USD 75.69 Bn

Medical engineered materials play a crucial role in the healthcare industry, and provides innovative solutions for a wide range of applications. These materials are specifically designed to meet the unique requirements of medical devices, implants, and equipment. These offer exceptional strength, durability, and biocompatibility, ensuring safe and effective healthcare solutions. There has been significant advancement in materials science and engineering which has expanded the use of materials like ceramics, metals, polymers, and composites in healthcare. Newer bioengineered materials are being developed that can closely mimic human tissues and aid in tissue regeneration. The advances are driven by the need for improved patient outcomes along with increasing complexity of medical procedures and treatments. Overall, the medical engineered materials industry plays a crucial role in developing innovative materials solutions that can elevate healthcare to the next level.

Market Dynamics:

Global medical engineered materials market growth is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and cancer is expected to boost demand for medical devices and implants. These materials offer exceptional properties including biocompatibility, durability, and flexibility, which are crucial in the development of advanced medical devices. Rising geriatric population worldwide is contributing to the market growth. The elderly population is more susceptible to chronic diseases and requires specialized medical treatments, which necessitate the use of medical engineered materials. Moreover, technological advancements in material science, such as the development of bio-based materials and nanotechnology-based coatings, are further driving market growth.

However, the market faces few challenges. Stringent regulations and quality standards imposed by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), can pose hurdles for market players. Compliance with these regulations and obtaining regulatory approvals for new materials can be time-consuming and costly. Furthermore, the high cost associated with the development and manufacturing of medical engineered materials can act as a restraint for market growth.

Key features of the study:

  • This report provides in-depth analysis of the global medical engineered materials market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical engineered materials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc.,
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical engineered materials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical engineered materials market

Medical Engineered Materials Market Detailed Segmentation:

  • By Product Type
    • Metallic Biomaterials
    • Ceramics Biomaterials
    • Polymeric Biomaterials
    • Natural Biomaterials
    • Composites Biomaterials
    • Others
  • By Application
    • Cardiovascular
    • Orthopedic
    • Dental
    • Plastic Surgery
    • Wound Healing
    • Neuro-logical
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Research Institutions
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Evonik Industries AG
    • Covestro AG
    • BASF SE
    • Solvay
    • SABIC
    • Trelleborg AB
    • DSM
    • Celanese Corporation
    • DuPont de Nemours Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Medical Engineered Materials Market, By Product Type
    • Medical Engineered Materials Market, By Application
    • Medical Engineered Materials Market, By End User
    • Medical Engineered Materials Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of chronic diseases
    • Stringent clinical & regulatory requirements
    • Applications in personalized medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Medical Engineered Materials Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Medical Engineered Materials Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Metallic Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Ceramics Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Polymeric Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Natural Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Composites Biomaterials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Medical Engineered Materials Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Plastic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Neuro-logical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Medical Engineered Materials Market , By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Medical Engineered Materials Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Argentina
      • Brazil
      • Mexico
      • Rest of Latin America

9. Middle East & Africa

  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • South Africa
      • Central Africa
      • North Africa
      • Rest of Middle East

10. Competitive Landscape

  • Evonik Industries AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covestro AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Solvay
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SABIC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trelleborg AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celanese Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • DuPont de Nemours Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us